middle.news
Why Is Virginia Commonwealth University Joining Imricor’s VISABL-AFL Trial?
9:22am on Wednesday 21st of January, 2026 AEDT
•
Healthcare
Read Story
Why Is Virginia Commonwealth University Joining Imricor’s VISABL-AFL Trial?
9:22am on Wednesday 21st of January, 2026 AEDT
Key Points
VCU Health approved by Institutional Review Board to join VISABL-AFL trial
Third US clinical trial site supporting Imricor’s FDA approval process
Procedures expected to start in March 2026 after installation and training
Trial uses MRI-guided cardiac ablation technology for improved patient outcomes
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMRICOR MEDICAL SYSTEMS (ASX:IMR)
OPEN ARTICLE